Bristol-Myers Sued over Generic Cancer Drug

Knight Trading denies trading allegations; Flextronics finishes lower; plus more of today's stocks in the news

Bristol-Myers Squibb (BMY ) is being sued by several states on allegations that the company improperly sought to delay generic competition for its widely used anti-cancer drug Taxol.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.